XORTX Announces Private Placement
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICESOR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Jan. 07, 2021 (GLOBE
Read moreCA98420Q1081
XORTX Announces Grant of European Patent
● Patent supporting Autosomal Dominant PolycysticKidney Disease Granted – XRx-008 Program ● CALGARY, Alberta, Dec. 29, 2020 (GLOBE NEWSWIRE) —
Read moreXORTX Announces Topline Results from Mount Sinai’s COVID-19 Clinical Study
● Early & High Uric Acid dose dependent association in Acute Kidney Injury from COVID-19 ● CALGARY, Alberta, Nov. 16,
Read moreXORTX Participation in Virtual Conferences
CALGARY, Alberta, Oct. 28, 2020 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (CSE: XRX) (OTCQB: XRTXF), a
Read moreXORTX Participation in Virtual Conferences
CALGARY, Alberta, Oct. 28, 2020 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (CSE: XRX) (OTCQB: XRTXF), a
Read moreXORTX Reports Annual & Special Meeting Results
CALGARY, Alberta, Oct. 23, 2020 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (CSE: XRX) (OTCQB: XRTXF), a
Read moreXORTX Reports Annual & Special Meeting Results
CALGARY, Alberta, Oct. 23, 2020 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (CSE: XRX) (OTCQB: XRTXF), a
Read moreXORTX Receives Positive Feedback from FDA on COVID-19 Related Acute Kidney Injury
● Clear Development Path Forward for XRx-101 ● CALGARY, Alberta, Oct. 08, 2020 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX”
Read moreXORTX Announces Change to Board of Directors
CALGARY, Alberta, Aug. 28, 2020 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (CSE : XRX) (OTCQB : XRTXF) (FRANKFURT : ANU1) (the
Read moreXORTX Appoints Dr. David Sans in New York as Director Corporate Development
CALGARY, Alberta, Aug. 07, 2020 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (CSE: XRX) (OTCQB: XRTXF), a
Read more